430 related articles for article (PubMed ID: 25922143)
1. Outcome for stage II and III rectal and colon cancer equally good after treatment improvement over three decades.
Fischer J; Hellmich G; Jackisch T; Puffer E; Zimmer J; Bleyl D; Kittner T; Witzigmann H; Stelzner S
Int J Colorectal Dis; 2015 Jun; 30(6):797-806. PubMed ID: 25922143
[TBL] [Abstract][Full Text] [Related]
2. Survival outcome of local excision versus radical resection of colon or rectal carcinoma: a Surveillance, Epidemiology, and End Results (SEER) population-based study.
Bhangu A; Brown G; Nicholls RJ; Wong J; Darzi A; Tekkis P
Ann Surg; 2013 Oct; 258(4):563-9; discussion 569-71. PubMed ID: 23979270
[TBL] [Abstract][Full Text] [Related]
3. Comparative Outcomes of Neoadjuvant Treatment Prior to Total Mesorectal Excision and Total Mesorectal Excision Alone in Selected Stage II/III Low and Mid Rectal Cancer.
Kulu Y; Tarantino I; Billeter AT; Diener MK; Schmidt T; Büchler MW; Ulrich A
Ann Surg Oncol; 2016 Jan; 23(1):106-13. PubMed ID: 26305025
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant 5FU plus levamisole in colonic or rectal cancer: improved survival in stage II and III.
Taal BG; Van Tinteren H; Zoetmulder FA;
Br J Cancer; 2001 Nov; 85(10):1437-43. PubMed ID: 11720425
[TBL] [Abstract][Full Text] [Related]
5. Verification of a new clinicopathologic staging system for colorectal adenocarcinoma.
Michelassi F; Ayala JJ; Balestracci T; Goldberg R; Chappell R; Block GE
Ann Surg; 1991 Jul; 214(1):11-8. PubMed ID: 2064465
[TBL] [Abstract][Full Text] [Related]
6. [Local recurrence and survival rate after rectal cancer operations and multimodal therapy].
Thomschke D; Kyau-Ummen B; Halbfass HJ
Chirurg; 2002 Mar; 73(3):245-54. PubMed ID: 11963499
[TBL] [Abstract][Full Text] [Related]
7. Increased Lymph Node Yield Is Associated With Improved Survival in Rectal Cancer Irrespective of Neoadjuvant Treatment: Results From a National Cohort Study.
Lykke J; Jess P; Roikjaer O;
Dis Colon Rectum; 2015 Sep; 58(9):823-30. PubMed ID: 26252843
[TBL] [Abstract][Full Text] [Related]
8. Disease-free survival after complete mesocolic excision compared with conventional colon cancer surgery: a retrospective, population-based study.
Bertelsen CA; Neuenschwander AU; Jansen JE; Wilhelmsen M; Kirkegaard-Klitbo A; Tenma JR; Bols B; Ingeholm P; Rasmussen LA; Jepsen LV; Iversen ER; Kristensen B; Gögenur I;
Lancet Oncol; 2015 Feb; 16(2):161-8. PubMed ID: 25555421
[TBL] [Abstract][Full Text] [Related]
9. Improvements in 5-year outcomes of stage II/III rectal cancer relative to colon cancer.
Renouf DJ; Woods R; Speers C; Hay J; Phang PT; Fitzgerald C; Kennecke H
Am J Clin Oncol; 2013 Dec; 36(6):558-64. PubMed ID: 22868238
[TBL] [Abstract][Full Text] [Related]
10. Resection of pulmonary metastases from colon and rectal cancer: factors to predict survival differ regarding to the origin of the primary tumor.
Meimarakis G; Spelsberg F; Angele M; Preissler G; Fertmann J; Crispin A; Reu S; Kalaitzis N; Stemmler M; Giessen C; Heinemann V; Stintzing S; Hatz R; Winter H
Ann Surg Oncol; 2014 Aug; 21(8):2563-72. PubMed ID: 24668147
[TBL] [Abstract][Full Text] [Related]
11. Laparoscopic surgery for colon and rectal cancer.
Bärlehner E; Benhidjeb T; Anders S; Schicke B
Surg Technol Int; 2004; 13():93-9. PubMed ID: 15744680
[TBL] [Abstract][Full Text] [Related]
12. Postoperative morbidity and mortality after mesorectal excision with and without lateral lymph node dissection for clinical stage II or stage III lower rectal cancer (JCOG0212): results from a multicentre, randomised controlled, non-inferiority trial.
Fujita S; Akasu T; Mizusawa J; Saito N; Kinugasa Y; Kanemitsu Y; Ohue M; Fujii S; Shiozawa M; Yamaguchi T; Moriya Y;
Lancet Oncol; 2012 Jun; 13(6):616-21. PubMed ID: 22591948
[TBL] [Abstract][Full Text] [Related]
13. National Early Rectal Cancer Treatment Revisited.
Stornes T; Wibe A; Nesbakken A; Myklebust TÅ; Endreseth BH
Dis Colon Rectum; 2016 Jul; 59(7):623-9. PubMed ID: 27270514
[TBL] [Abstract][Full Text] [Related]
14. Metastatic lymph node ratio in stage III rectal carcinoma is a valuable prognostic factor even with less than 12 lymph nodes retrieved: a prospective study.
Madbouly KM; Abbas KS; Hussein AM
Am J Surg; 2014 Jun; 207(6):824-31. PubMed ID: 24112666
[TBL] [Abstract][Full Text] [Related]
15. [The role of lymphadenectomy in the surgical treatment of cancer of the left colon and rectum].
Briccoli A; Beghi M; Farinetti A; Guernelli N
Minerva Chir; 1990 Feb; 45(3-4):141-3. PubMed ID: 2356026
[TBL] [Abstract][Full Text] [Related]
16. Influence of pT3 subgroups on outcome of R0-resected colorectal tumors.
Mrak K; Jagoditsch M; Leibl S; Klingler A; Tschmelitsch J
South Med J; 2011 Nov; 104(11):722-30. PubMed ID: 22024778
[TBL] [Abstract][Full Text] [Related]
17. [Total excision of the mesorectum in cancer of the lower and middle rectum. Oncological and functional results].
Kneist W; Heintz A; Wolf HK; Junginger T
Chirurg; 2003 Feb; 74(2):125-31. PubMed ID: 12599030
[TBL] [Abstract][Full Text] [Related]
18. Variation in colorectal cancer treatment and survival: a cohort study covering the East Anglia region.
Warwick J; Will O; Allgood P; Miller R; Duffy S; Greenberg D
Colorectal Dis; 2013; 15(10):1243-52. PubMed ID: 23710604
[TBL] [Abstract][Full Text] [Related]
19. Improved survival of colorectal cancer in Denmark during 2001-2012 - The efforts of several national initiatives.
Iversen LH; Green A; Ingeholm P; Østerlind K; Gögenur I
Acta Oncol; 2016 Jun; 55 Suppl 2():10-23. PubMed ID: 26859340
[TBL] [Abstract][Full Text] [Related]
20. Prediction of treatment outcome by CD44v6 after total mesorectal excision in locally advanced rectal cancer.
Peng J; Lu JJ; Zhu J; Xu Y; Lu H; Lian P; Cai G; Cai S
Cancer J; 2008; 14(1):54-61. PubMed ID: 18303484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]